GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 50 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $50,000 | -51.0% | 10,500 | -65.6% | 0.01% | -53.3% |
Q4 2017 | $102,000 | +56.9% | 30,500 | 0.0% | 0.02% | +50.0% |
Q3 2017 | $65,000 | -13.3% | 30,500 | 0.0% | 0.01% | -23.1% |
Q2 2017 | $75,000 | +7.1% | 30,500 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $70,000 | +133.3% | 30,500 | 0.0% | 0.01% | +116.7% |
Q4 2016 | $30,000 | -11.8% | 30,500 | 0.0% | 0.01% | -14.3% |
Q3 2016 | $34,000 | -24.4% | 30,500 | 0.0% | 0.01% | -30.0% |
Q2 2016 | $45,000 | +2.3% | 30,500 | 0.0% | 0.01% | +11.1% |
Q1 2016 | $44,000 | -12.0% | 30,500 | 0.0% | 0.01% | -10.0% |
Q4 2015 | $50,000 | -29.6% | 30,500 | 0.0% | 0.01% | -41.2% |
Q3 2015 | $71,000 | -14.5% | 30,500 | 0.0% | 0.02% | +6.2% |
Q2 2015 | $83,000 | -18.6% | 30,500 | 0.0% | 0.02% | -15.8% |
Q1 2015 | $102,000 | -3.8% | 30,500 | 0.0% | 0.02% | 0.0% |
Q4 2014 | $106,000 | -4.5% | 30,500 | +38.6% | 0.02% | -9.5% |
Q3 2014 | $111,000 | – | 22,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
Virtu Financial LLC | 14,683 | $32,000 | 0.00% |